The Oncology Institute, Inc. TOI Operating Lease Liability - Undiscounted Excess Amount
Operating Lease Liability - Undiscounted Excess Amount at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s operating lease liability - undiscounted excess amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s operating lease liability - undiscounted excess amount?
- The Oncology Institute, Inc. (TOI) reported operating lease liability - undiscounted excess amount of $3.97M in Q1 2026.
- How has The Oncology Institute, Inc.'s operating lease liability - undiscounted excess amount changed year-over-year?
- The Oncology Institute, Inc.'s operating lease liability - undiscounted excess amount decreased by 16.5% year-over-year, from $4.75M to $3.97M.
- What does operating lease liability - undiscounted excess amount mean?
- This represents the difference between the total undiscounted future lease payments and the present value of those payments recorded on the balance sheet. It effectively quantifies the interest component embedded within operating lease obligations. It is a measure of the financing cost inherent in the lease portfolio.